| Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database AJ Tyndall, B Bannert, M Vonk, P Airò, F Cozzi, PE Carreira, DF Bancel, ... Annals of the rheumatic diseases 69 (10), 1809-1815, 2010 | 1492 | 2010 |
| A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis P Emery, FC Breedveld, EM Lemmel, JP Kaltwasser, PT Dawes, B Gömör, ... Rheumatology 39 (6), 655-665, 2000 | 653 | 2000 |
| Mapping and predicting mortality from systemic sclerosis M Elhai, C Meune, M Boubaya, J Avouac, E Hachulla, A Balbir-Gurman, ... Annals of the rheumatic diseases 76 (11), 1897-1905, 2017 | 531 | 2017 |
| Chorea in the antiphospholipid syndrome-Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature R Cervera, RA Asherson, J Font, M Tikly, L Pallares-Ferreres, A Chamorro, ... Medicine 76 (3), 203-212, 1997 | 307 | 1997 |
| Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study VK Jaeger, EG Wirz, Y Allanore, P Rossbach, G Riemekasten, E Hachulla, ... PloS one 11 (10), e0163894, 2016 | 220 | 2016 |
| Digital ulcers predict a worse disease course in patients with systemic sclerosis C Mihai, R Landewé, D Van Der Heijde, UA Walker, PI Constantin, ... Annals of the rheumatic diseases 75 (4), 681-686, 2016 | 177 | 2016 |
| Causes and predictors of death in South Africans with systemic lupus erythematosus S Wadee, M Tikly, M Hopley Rheumatology 46 (9), 1487-1491, 2007 | 163 | 2007 |
| IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic … TB Niewold, JA Kelly, SN Kariuki, BS Franek, AA Kumar, KM Kaufman, ... Annals of the rheumatic diseases 71 (3), 463-469, 2012 | 158 | 2012 |
| Joint and tendon involvement predict disease progression in systemic sclerosis: a EUSTAR prospective study J Avouac, UA Walker, E Hachulla, G Riemekasten, G Cuomo, PE Carreira, ... Annals of the rheumatic diseases 75 (1), 103-109, 2016 | 152 | 2016 |
| Rheumatoid arthritis in the developing world AA Kalla, M Tikly Best Practice & Research Clinical Rheumatology 17 (5), 863-875, 2003 | 143 | 2003 |
| A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study M Elhai, J Avouac, UA Walker, M Matucci-Cerinic, G Riemekasten, P Airò, ... Annals of the rheumatic diseases 75 (1), 163-169, 2016 | 139 | 2016 |
| Lupus in the developing world–is it any different? M Tikly, SV Navarra Best Practice & Research Clinical Rheumatology 22 (4), 643-655, 2008 | 137 | 2008 |
| Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. M Rudwaleit, M Tikly, M Khamashta, K Gibson, J Klinke, G Hughes, ... The Journal of Rheumatology 23 (10), 1725-1728, 1996 | 115 | 1996 |
| Functional disability and health-related quality of life in South Africans with rheumatoid arthritis and systemic lupus erythematosus R Benitha, M Tikly Clinical rheumatology 26, 24-29, 2007 | 109 | 2007 |
| Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database EG Wirz, VK Jaeger, Y Allanore, G Riemekasten, E Hachulla, O Distler, ... Annals of the rheumatic diseases 75 (7), 1285-1292, 2016 | 98 | 2016 |
| Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans. RE Tager, M Tikly Rheumatology 38 (5), 397-400, 1999 | 98 | 1999 |
| Autoantibodies in black South Africans with systemic lupus erythematosus: spectrum and clinical associations M Tikly, S Burgin, P Mohanlal, A Bellingan, J George Clinical rheumatology 15, 143-147, 1996 | 95 | 1996 |
| Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic sclerosis V Sobanski, J Giovannelli, Y Allanore, G Riemekasten, P Airò, S Vettori, ... Arthritis & rheumatology 71 (9), 1553-1570, 2019 | 92 | 2019 |
| Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis MMTM Ally, B Hodkinson, PWA Meyer, E Musenge, M Tikly, R Anderson Mediators of inflammation 2013, 2013 | 84 | 2013 |
| The clinical utility of accelerometry in patients with rheumatoid arthritis A Prioreschi, B Hodkinson, I Avidon, M Tikly, JA McVeigh Rheumatology 52 (9), 1721-1727, 2013 | 78 | 2013 |
Eustasius MusengeSenior Lecturer / Senior BiostatisticianVerified email at wits.ac.za
